Top in women's health: Survey on perimenopausal care; dangers of delayed colposcopy

In a survey sent to women about midlife care, almost half of the respondents reported negative health care interactions. Only 18% reported positive or satisfying health care interactions.

This was the top story in women’s health last week.

The second top story was about how women who do not undergo colposcopy within 12 months of an abnormal Pap or HPV test result have a higher risk for cervical cancer.

Read these and more top stories in women’s health below:

Survey identifies ways to improve midlife care for perimenopausal women

Women who sought health care for bothersome perimenopausal symptoms reported both positive and negative experiences in interactions with providers, according to results of the Women Living Better survey. Read more.

Cervical cancer risk rises with colposcopy delay after abnormal test results

Women with abnormal Pap or HPV test results who did not undergo colposcopy within 12 months had higher risk for subsequent cervical cancer compared with women who received colposcopy within that time frame, researchers reported. Read more.

Higher endometrial cancer, hyperplasia rates with conjugated estrogens/bazedoxifene

In the first years of use, women prescribed conjugated estrogens/bazedoxifene vs. estrogen/progestin for menopausal symptoms may have higher rates of endometrial cancer and endometrial hyperplasia but lower breast cancer rates. Read more.

Survey: 42% of midlife women have used cannabis, 6% for menopause symptoms

Medical and recreational cannabis use by midlife women may be “relatively common,” with 6% of those who reported use saying they use the drug to address symptoms of menopause, according to a speaker. Read more.

RUBY: Intrauterine device successfully decreases postpartum uterine bleeding

An intrauterine vacuum-induced hemorrhage control device successfully decreased abnormal postpartum uterine bleeding, according to results of the real-world RUBY study. Read more.